Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality

Miguel Chavez; McHale Anderson; Christos P. Kyriakopoulos; Monte Scott; Elizabeth Dranow; Eleni Maneta; Rana Hamouche; Iosif Taleb; Jacy Leon; Benjamin Kogelschatz; Jake Goldstein; Filio Billia; David A. Baran; Behnam Tehrani; Matt Goodwin; Craig H. Selzman; Joseph E. Tonna; James C. Fang; Stavros G. Drakos; Thomas C. Hanff

doi:10.1161/circheartfailure.124.011827

Key Points

Pathophysiologic vasodilation occurs alongside inadequate cardiac output during severe cardiogenic shock, compromising systemic perfusion and survival.
Mortality reaches nearly 40% in cardiogenic shock, where unexpected systemic vasodilation further diminishes arterial pressure and tissue perfusion.
Clinical assessment investigates the prevalence and physiological impacts of vasodilation in cardiogenic shock, highlighting critical therapeutic needs.

Implication

Observational evaluation reveals pathophysiologic vasodilation during cardiogenic shock, indicating vascular dysfunction impairs survival.

Abstract

Cardiogenic shock (CS) mortality remains near 40%. In addition to inadequate cardiac output, patients with severe CS may exhibit vasodilation. We aimed to examine the prevalence and consequences of vasodilation in CS.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chavez et al. (2024) studied this question.

synapsesocial.com/papers/68e5f0a2b6db643587585270 https://doi.org/10.1161/circheartfailure.124.011827

View Full Paper

Ask AI

Bookmark

Share

Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality

Key Points

Implication

Abstract

Discussion

Cite This Study

Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading